A New Study Released by the University of Rome validates the efficacy of Chanson Alkaline Water in Cancer Prevention! In the article titled, Electrochemically Reduced Water Delays Mammary Tumors Growth in Mice and Inhibits Breast Cancer Cells in Vitro led by Giovanni Vanni Frajese MD at the University of Rome, Dr. Frajese and his colleagues outline the results of their laboratory studies in which they found that Electrochemically Reduced Water (ERW) created using the Chanson Miracle M.A.X delayed the growth of tumors in mice, and inhibited breast cancer cells in vitro, meaning in cell cultures outside of the body.
For those who were unsure or skeptical about the benefits of alkaline water, we finally have scientific proof backed by University Research!? In the major findings of the study, it states, “ERW induced a significant prolongation of tumor-free survival and a reduction in tumor multiplicity. Overall, these results suggest a potential beneficial role of ERW in inhibiting cancer cells growth.”. Simply put, the water produced specifically by our Chanson Miracle M.A.X. plays a beneficial role in cancer prevention.
This marks the first time that a company has had their technology used in a major research study on electrochemically reduced water. This marks a turning point in the area of water research, and we hope is the beginning of a new era. We could not be more proud of our Chanson products, knowing the many lives that will benefit as a result of using the electron rich, electrochemically reduced alkaline water they produce.
For more information on the machine used in this study, visit the Chanson Miracle Max product page on our website.
Electrochemical reduced water (ERW) has been proposed to have beneficial effects on human health due to its rich content of H2 and the presence of platinum nanoparticles with antioxidant effects. Many studies have demonstrated that ERW scavenging properties are able to reduce the damage caused by oxidative stress in different experimental models. Although few in vivo studies have been reported, it has been demonstrated that ERW may display anticancer effects by induction of tumor cells apoptosis and reduction of both angiogenesis and inflammation. In this study, we show that ERW treatment of MCF-7, MDA-MB-453, and mouse (TUBO) breast cancer cells inhibited cell survival in a time-dependent fashion. ERW decreased ErbB2/neu expression and impaired pERK1/ERK2 and AKT phosphorylation in breast cancer cells. In addition, ERW treatment induced apoptosis of breast cancer cell lines independently of the status of p53 and ER and PR receptors. Our in vivo results showed that ERW treatment of transgenic BALB-neuT mice delayed the development of mammary tumors compared to the control. In addition, ERW induced a significant prolongation of tumor-free survival and a reduction in tumor multiplicity. Overall, these results suggest a potential beneficial role of ERW in inhibiting cancer cells growth.